Abstract
Physicians’ “know-do gaps” are a key factor driving the poor quality of healthcare in many developing countries, but there is little guidance on how to address these gaps. We designed a standardised patient audit study in China to evaluate the impact of physician over-service on their investment in learning and disease management decisions. We find that physicians’ total over-service leads to a 19.2%, 15.6% and 10.8% significant increase in consultation length, adherence to checklists, and patient-centred communication, respectively, but no significant improvement in giving a correct diagnosis, drug prescription or referral. The effects on physicians’ investment in learning are driven by over-service in drug prescription rather than over-service in medical tests. Moreover, over-service in drug prescription significantly leads to a 28.0 percentage-point increase in the prescription of a correct drug. Our findings imply that physician over-service reduces their “know-do gaps” and improves healthcare quality despite the related inefficient use of medical resources.
JEL classification D82; H75; I10; I11; I18; J45
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the China Medical Board, USA (15-227); National Natural Science Foundation of China, China (71874137); the University of New South Wales, Australia; Australian Research Council Centre of Excellence in Population Ageing Research (project CE170100005), Australia.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Ethics Committee of Xi'an Jiaotong University Health Science Centre (Approval number: 2015-406) and the Ethics Committee of the University of New South Wales (HC210354).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
